You are here

An Efficacy Trial of Mobile Technology for Reducing and Preventing Adolescent Suicide

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 2R42MH125691-02
Agency Tracking Number: R42MH125691
Amount: $766,481.00
Phase: Phase II
Program: STTR
Solicitation Topic Code: 104
Solicitation Number: PA21-261
Timeline
Solicitation Year: 2021
Award Year: 2023
Award Start Date (Proposal Award Date): 2023-04-01
Award End Date (Contract End Date): 2026-03-31
Small Business Information
4 SCIENCE PARK
New Haven, CT 06511
United States
DUNS: 081133796
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 PATRICIA SIMON
 (203) 725-4024
 patricia.simon01@gmail.com
Business Contact
 BRIAN KEENAGHAN
Phone: (203) 725-4024
Email: brian@ouitherapeutics.com
Research Institution
 HARTFORD HOSPITAL
 
80 SEYMOUR STREET
HARTFORD, CT 06102-5037
United States

 Domestic Nonprofit Research Organization
Abstract

ABSTRACT
Suicide is a leading cause of death in the US and suicide rates have steadily increased. Despite this, there is a
paucity of interventions that reduce suicide ideation and behavior. In this project, we seek to enhance a beta
version of our suicide prevention digital therapeutic (developed in phase I) and conduct a randomized
controlled trial to evaluate the efficacy of the digital therapeutic for suicide-related outcomes. This project will
contribute to our understanding of the use of mobile technology as a suicide prevention tool.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government